Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual Behavior, Animal | 10 | 2015 | 65 | 2.070 |
Why?
|
| Neurosecretory Systems | 4 | 2018 | 66 | 1.790 |
Why?
|
| Receptors, Progesterone | 5 | 2012 | 1392 | 1.210 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2018 | 110 | 0.930 |
Why?
|
| Homeostasis | 2 | 2018 | 950 | 0.790 |
Why?
|
| Reproduction | 2 | 2018 | 253 | 0.680 |
Why?
|
| Brain | 5 | 2012 | 4113 | 0.610 |
Why?
|
| Hypothalamus | 3 | 2008 | 255 | 0.610 |
Why?
|
| Progesterone | 3 | 2008 | 513 | 0.600 |
Why?
|
| Steroid Hydroxylases | 1 | 2015 | 36 | 0.530 |
Why?
|
| Stress, Psychological | 2 | 2018 | 1000 | 0.460 |
Why?
|
| Energy Metabolism | 1 | 2018 | 992 | 0.430 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 18 | 0.420 |
Why?
|
| Estradiol | 2 | 2012 | 748 | 0.400 |
Why?
|
| Anti-Anxiety Agents | 1 | 2011 | 90 | 0.390 |
Why?
|
| Estrogen Receptor beta | 1 | 2011 | 155 | 0.390 |
Why?
|
| Sex Characteristics | 2 | 2013 | 417 | 0.380 |
Why?
|
| Behavior, Animal | 2 | 2011 | 709 | 0.380 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2008 | 184 | 0.370 |
Why?
|
| Sexual Behavior | 1 | 2012 | 310 | 0.360 |
Why?
|
| Protein Kinase C | 2 | 2008 | 396 | 0.350 |
Why?
|
| Neurotransmitter Agents | 1 | 2010 | 159 | 0.340 |
Why?
|
| Ovariectomy | 4 | 2012 | 330 | 0.340 |
Why?
|
| Inflammation | 1 | 2018 | 2522 | 0.330 |
Why?
|
| Behavior | 1 | 2008 | 103 | 0.310 |
Why?
|
| Linoleic Acids | 2 | 2007 | 32 | 0.290 |
Why?
|
| Furans | 2 | 2007 | 104 | 0.280 |
Why?
|
| Animals | 21 | 2018 | 59536 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2012 | 2063 | 0.250 |
Why?
|
| Estrogens | 3 | 2014 | 751 | 0.240 |
Why?
|
| Rats | 7 | 2012 | 6086 | 0.230 |
Why?
|
| Anxiety | 3 | 2015 | 1179 | 0.210 |
Why?
|
| Neurons | 2 | 2014 | 2287 | 0.210 |
Why?
|
| Mice, Knockout | 6 | 2015 | 5710 | 0.190 |
Why?
|
| Preoptic Area | 3 | 2008 | 7 | 0.180 |
Why?
|
| Zea mays | 3 | 2007 | 46 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2013 | 4804 | 0.160 |
Why?
|
| Stearic Acids | 2 | 2007 | 10 | 0.150 |
Why?
|
| Estrous Cycle | 2 | 2007 | 37 | 0.140 |
Why?
|
| Sex Differentiation | 1 | 2016 | 41 | 0.140 |
Why?
|
| Cytochrome P450 Family 7 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Calbindins | 1 | 2015 | 21 | 0.130 |
Why?
|
| Ligands | 2 | 2010 | 995 | 0.130 |
Why?
|
| Female | 17 | 2016 | 141928 | 0.130 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 113 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2008 | 1764 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 2008 | 621 | 0.120 |
Why?
|
| Spermatogenesis | 1 | 2015 | 308 | 0.120 |
Why?
|
| Serotonin | 1 | 2014 | 264 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2013 | 76 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 7548 | 0.110 |
Why?
|
| Mice | 8 | 2015 | 34495 | 0.110 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2011 | 4 | 0.110 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2013 | 167 | 0.100 |
Why?
|
| Propionates | 1 | 2011 | 71 | 0.100 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 354 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 488 | 0.090 |
Why?
|
| Housing, Animal | 2 | 2005 | 38 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 862 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 22 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1070 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3639 | 0.080 |
Why?
|
| Benzylamines | 1 | 2008 | 105 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 808 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2011 | 492 | 0.080 |
Why?
|
| Dopamine | 1 | 2010 | 312 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 234 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2010 | 11965 | 0.080 |
Why?
|
| Nitriles | 1 | 2011 | 906 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1271 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 225 | 0.070 |
Why?
|
| Endocrine Disruptors | 1 | 2007 | 53 | 0.070 |
Why?
|
| Mitogens | 1 | 2005 | 75 | 0.070 |
Why?
|
| Phytoestrogens | 1 | 2005 | 26 | 0.070 |
Why?
|
| Hydroxylation | 1 | 2005 | 65 | 0.070 |
Why?
|
| Mifepristone | 1 | 2006 | 147 | 0.070 |
Why?
|
| Activin Receptors, Type II | 1 | 2005 | 38 | 0.070 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 85 | 0.070 |
Why?
|
| Benzazepines | 1 | 2006 | 108 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2086 | 0.060 |
Why?
|
| Posture | 1 | 2006 | 215 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2013 | 2295 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 6942 | 0.060 |
Why?
|
| Male | 8 | 2016 | 123000 | 0.060 |
Why?
|
| Humans | 8 | 2018 | 261506 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 4757 | 0.050 |
Why?
|
| Indoles | 1 | 2008 | 1009 | 0.050 |
Why?
|
| Calcium | 1 | 2008 | 1537 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 4053 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2008 | 1823 | 0.040 |
Why?
|
| Motor Activity | 2 | 2013 | 693 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 6 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2014 | 35 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 67 | 0.030 |
Why?
|
| Sensory Gating | 1 | 2013 | 14 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2013 | 10 | 0.030 |
Why?
|
| Nociception | 1 | 2013 | 45 | 0.030 |
Why?
|
| Locomotion | 1 | 2013 | 84 | 0.030 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2005 | 7226 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 2013 | 41 | 0.030 |
Why?
|
| Motor Skills | 1 | 2013 | 107 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2013 | 107 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2013 | 142 | 0.030 |
Why?
|
| Thiophenes | 1 | 2013 | 148 | 0.030 |
Why?
|
| Mutation | 1 | 2011 | 15179 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 769 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2013 | 423 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 284 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 429 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 701 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 803 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 923 | 0.020 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2007 | 6 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 95 | 0.020 |
Why?
|
| Receptors, Estradiol | 1 | 2005 | 2 | 0.020 |
Why?
|
| Tritium | 1 | 2005 | 200 | 0.020 |
Why?
|
| Copulation | 1 | 2005 | 9 | 0.020 |
Why?
|
| Aromatase | 1 | 2005 | 56 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2005 | 300 | 0.020 |
Why?
|
| Olfactory Pathways | 1 | 2005 | 47 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 165 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 2466 | 0.020 |
Why?
|
| Penis | 1 | 2005 | 123 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 314 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3570 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 548 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 14551 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 1341 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 1099 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 974 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 6295 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 2307 | 0.010 |
Why?
|
| Testosterone | 1 | 2005 | 619 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 2139 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2005 | 878 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 4938 | 0.010 |
Why?
|